The Food and Drug Administration (FDA) has flagged a rare but potential link between the RSV vaccine—particularly Arexvy—and ...

A new Cochrane review bolsters confidence in the safety and effectiveness of RSV vaccines for older adults and pregnant ...

As respiratory syncytial virus (RSV) season approaches, the American Lung Association is spotlighting new data that show a dramatic decrease in RSV-related hospitalizations among infants, thanks to ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

RSV is the leading cause of infant hospitalizations in the U.S. But that could soon change as research advances lead to new ...

A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in ...

Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

What is RSV? RSV (respiratory syncytial virus), as the name suggests, is a virus that primarily infects respiratory cells. It ...

Enanta Pharmaceuticals said its experimental respiratory syncytial virus treatment significantly quickened recovery in a mid-stage study of adults at high risk of complications from the infection.

Uptake of the respiratory syncytial virus (RSV) vaccine during pregnancy is not linked to increased risk of adverse perinatal ...

Enanta is advancing zelicapavir to Phase III trials after CMO Dr Scott Rottinghaus said it is justified by the Phase IIb data ...

New Hampshire Dept. of Health and Human Services says flu, COVID-19 and RSV immunizations are available across the state and ...